KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with tag medical .

ERA-Net funding for support photonics-based sensing technologies including medical applications

Businesses can apply for a share of funding under Horizon 2020’s ERA-NET co-funded competition to support photonics-based sensing technologies. They are inviting proposals for the following application areas: safety, including food safety civil security manufacturing and production environmental monitoring medical applications   ...
Read More About ERA-Net funding for support photonics-based sensing technologies including medical applications »

The future of biopharmaceutical formulation - making better products with novel approaches

KTN Biopharmaceutical Formulation Group The future of biopharmaceutical formulation - making better products with novel approaches UCL, London Thursday 7th July, 2016 The KTN’s Biopharmaceutical Formulation Group will meet on 7th July at an event hosted by the EPSRC Centre for Innovative Manufacturing at UCL. The event is an opportunity to hear from industry and academia in...
Read More About The future of biopharmaceutical formulation - making better products with novel approaches »

Latest Medtech Innovation Briefings from NICE

NICE Medtech Innovation Briefings are a product from NICE to support NHS and social care commissioners and staff who are considering using new medical devices and other medical technologies or diagnostic technologies. The information provided includes a description of the technology, how it’s used and its potential role in the treatment pathway. NICE Medtech Innovation briefings also...
Read More About Latest Medtech Innovation Briefings from NICE »

Advanced Therapies and Medicinal Products Ministerial Taskforce Update

The Advanced Therapies Manufacturing Taskforce originated from the work of the  Medicines Manufacturing Industry Partership  (MMIP), it is co-chaired by George Freeman MP, Minister for Life Sciences, and by me, the Chair of the MMIP. It is a short-term group which will meet three times over 2016 with the aim of anchoring advanced therapy manufacturing and its associated supply...
Read More About Advanced Therapies and Medicinal Products Ministerial Taskforce Update »

New company created to develop novel technology to treat diabetes

UK technology has potential to bring islet transplant therapy to thousands of patients with type 1 diabetes The Cell and Gene Therapy Catapult (CGT) and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production. The technology could bring the...
Read More About New company created to develop novel technology to treat diabetes »

Launch of Coast to Capital Region Business Growth Grants

Launch of Coast to Capital Region Business Growth Grants The aim of the Coast to Capital Region Business Growth Grants scheme is to support high growth businesses planning to create new jobs. A Capital grant of £15,000 - £100,000 is available covering up to 40% of project costs. Assistance is available to small and medium-sized businesses (SMEs) located within the Coast to...
Read More About Launch of Coast to Capital Region Business Growth Grants »

Innovation & Knowledge Centre funding competitions

The IKC are running two funding competitions: Translational Proof of Concept in partnership with Arthritis Research UK; and a Translational Feasibility Fund, both open to any academic in the UK Call for Submissions: Translational Proof of Concept Funding A maximum £100,000 support per project (up to 5 projects) to accelerate exciting innovations that support the...
Read More About Innovation & Knowledge Centre funding competitions »

How the UK Is Driving a Global Revolution of 21st Century Healthcare Innovation

Technology is transforming healthcare. The pace of biomedical science and genetics is leading to the discovery of new diagnostics and new drugs at an extraordinary pace. Cancer for example is now becoming a treatable and in some cases curable and preventable disease. Digitalisation is transforming individual care, systems safety and performance, and research. It is putting patients in...
Read More About How the UK Is Driving a Global Revolution of 21st Century Healthcare Innovation »

Medical Technologies mission to New Zealand

The British High Commission in New Zealand is pleased to announce that it will host a UK-to-NZ mission on Medical Technologies in June 2016. The mission will coincide with NZ’s Medical Technologies and Healthcare Congress  and associated events, scheduled to take place in Auckland, June 20 to 25, 2016. A UK Medical Technologies mission will pursue collaborative research...
Read More About Medical Technologies mission to New Zealand »

the future of medicine - the role of doctors in 2025

the future of medicine - the role of doctors in 2025 19th May Royal Society of Medicine 1 Wimpole Street LONDON W1G 0AE  The aim of this conference is to explore just how far the delivery of health and care has been improved by the availability of new technology, and what the latest predictions are by those working in the field of how medicine will really be...
Read More About the future of medicine - the role of doctors in 2025 »

EU Funding - Exploring the Opportunities

MediCity Scotland in conjunction with Enterprise Europe Scotland, the Digital Health & Medical Biotech Knowledge Transfer Networks invites you to: EU Funding Exploring the Opportunities Date & Time:  28th April 2016, 12.30 - 15.30  Location:  MediCity, Scotland Free to attend With up to €2.5million in funding, business support and mentoring...
Read More About EU Funding - Exploring the Opportunities »

Health Data Analytics in Japan - Big Opportunities for UK Companies: Webinar

UKTI Japan Webinar Big Data Analytics Japan 10.00am on Tue 26 April   The primary focus of this webinar is on the Japanese market related to Big Data, but as data analytics connects to an ever increasing spectrum of businesses and sectors including Biotech, Pharma, Medical and Healthcare, we believe there will be a lot of relevant information to your industry when...
Read More About Health Data Analytics in Japan - Big Opportunities for UK Companies: Webinar »

Building the Regenerative Devices Industry

Regener8-Medical Technologies IKC Annual Conference 1st July, LEEDS Regener8 and the Medical Technologies IKC are to host a one-day conference, focusing on best practice in translating regenerative devices – a potential £1bn industry in the UK.   Regener8 is the conference for academics, business people, managers and researchers working with innovation, enterprise,...
Read More About Building the Regenerative Devices Industry »

Össur acquires Touch Bionics

Össur acquires Touch Bionics Össur have recently signed an agreement to acquire Touch Bionics Limited, a leading global provider of innovative upper limb prostheses and supporting services. Touch Bionics has over 120 employees with operations in Scotland, Germany, and the United States. In 2015, total sales amounted to GBP 15 million (USD 21 million) with an adjusted EBITDA of GBP 0.9...
Read More About Össur acquires Touch Bionics »

Future Formulation Call Funded Projects

Following EPSRC's Future Formulation Call, seven projects have now been funded receiving £15 million across 9 institutions. Those projects funded include " Enabling rapid liquid and freeze-dried formulation design for the manufacture and delivery of novel biopharmaceuticals" (Manchester University) & " Enabling rapid liquid and freeze-dried formulation design for the manufacture and...
Read More About Future Formulation Call Funded Projects »

£30,000 to identify key research challenges in Regenerative Device Development

Call for submissions: Crowdsourcing competition £30,000 to identify key research challenges in Regenerative Device Development About this competition The Medical Technologies Innovation and Knowledge Centre (IKC) is partnering with Leeds University Business School to open a medical technologies innovation competition through crowdsourcing software. The...
Read More About £30,000 to identify key research challenges in Regenerative Device Development »

Cellular Reprogramming and Culture of hiPSCs: a practical training course and UK Stem Cell Bank workshop on gene-editing

Cellular Reprogramming and Culture of hiPSCs: a practical training course and UK Stem Cell Bank workshop on gene-editing  23rd to 26th May 2016. This event brings together three successful training and workshop activities in stem cell technology:  Harvard Stem Cell Institute/UK Stem Cell Bank reprogramming training course (23rd May), EBiSC practical training course in iPSC...
Read More About Cellular Reprogramming and Culture of hiPSCs: a practical training course and UK Stem Cell Bank workshop on gene-editing »

Medical Device Development : From Lab Bench to Bedside

MEDICAL DEVICE DEVELOPMENT FROM LAB BENCH TO BEDSIDE  12 April 2016, 18:00 One Birdcage Walk, London  FREE AND OPEN TO ALL  The UK has a strong medical device innovation record, both from academia and private research. A regular stream of devices emerge from biomedical engineering laboratories but fail to make it in the mainstream market as a result of the...
Read More About Medical Device Development : From Lab Bench to Bedside »

Discuva: Leading The Global Medical Search For New Lifesaving Antibiotics

A pharmaceutical company supported by Innovate UK is leading the world in the search for vital new antibiotics to treat resistant bacteria. Cambridge-based Discuva was able to speed up its efforts to discover new antibiotics using its ground-breaking technology after winning £1.6 million from Innovate UK’s Biomedical Catalyst fund in 2012. Discuva uses high-throughput microbial...
Read More About Discuva: Leading The Global Medical Search For New Lifesaving Antibiotics »

Industry taskforce launched to secure the future of manufacturing advanced therapy medicines in the UK

A new Advanced Therapy Manufacturing Taskforce has been launched by the Medicines Manufacturing Industry Partnership (MMIP) to secure the future of manufacturing advanced therapies in the UK. Co-chaired by Minister for Life Sciences George Freeman and Ian McCubbin, SVP North America, Japan & Global Pharma Supply, GlaxoSmithKline, the new taskforce will be working to...
Read More About Industry taskforce launched to secure the future of manufacturing advanced therapy medicines in the UK »

Important Industry/Academia BBSRC engagement opportunities & bioscience for health highlight

Under on-going implementation of the BBSRC strategy for maintaining and improving engagement with industry, BBSRC would like to highlight their Collaborative Training Partnerships  call and some of their regular industry collaborative research, training and people movement schemes which operate throughout the year.  Collaborative Training Partnerships (CTPs) – closing date...
Read More About Important Industry/Academia BBSRC engagement opportunities & bioscience for health highlight »

Priority Medicine Scheme launched by the European Medicines Agency

PRIME is a scheme launched by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier. Through PRIME, the...
Read More About Priority Medicine Scheme launched by the European Medicines Agency »

NICE recommends new sickle cell treatment device that could save the NHS millions

NICE is recommending a new device for managing sickle cell disease which makes treatment easier and quicker for patients, and could save the NHS in England around £13 million each year. The  NICE medical technology guidance  supports the use of the Spectra Optia Apheresis System for automated red blood cell exchange in patients with sickle cell disease who need regular...
Read More About NICE recommends new sickle cell treatment device that could save the NHS millions »

Albumedix Announces Exclusive Commercialization Agreement with ThioLogics for its Proprietary Drug Conjugation Platform

Albumedix havd announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates. The data demonstrates the serum stability advantages achieved by combining Albumedix's albumin-based drug delivery technology, Veltis®, with ThioLogics' site-specific Next Generation Maleimide (NGM)...
Read More About Albumedix Announces Exclusive Commercialization Agreement with ThioLogics for its Proprietary Drug Conjugation Platform »

TrakCel selected for EU CAR-T Cell Therapy Project

TrakCel Ltd., a leading provider of Clinical supply chain orchestration technology for Cell, Gene and Immunotherapies, today announced its selection as a key partner in CARAT, an EU-funded project to support the development of CAR T cell therapies. The CARAT (Chimeric Antigen Receptors (CARs) for Advanced Therapies) project aims to integrate innovative cell manufacturing tools and...
Read More About TrakCel selected for EU CAR-T Cell Therapy Project »
Showing 1 - 25 of 55 results.
Items per Page 25
of 3